These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19289631)

  • 1. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
    Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
    J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
    Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
    Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas.
    Gupta RK; Sharma MC; Suri V; Kakkar A; Singh M; Sarkar C
    J Neurooncol; 2014 Jan; 116(2):267-74. PubMed ID: 24178439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.
    Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T
    Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
    Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
    Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
    Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
    Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
    von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
    Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular staging of intracranial ependymoma in children and adults.
    Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
    J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
    Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of chromosome 1q gain in intracranial ependymomas.
    Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
    J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.
    Milde T; Pfister S; Korshunov A; Deubzer HE; Oehme I; Ernst A; Starzinski-Powitz A; Seitz A; Lichter P; von Deimling A; Witt O
    Genes Chromosomes Cancer; 2009 Mar; 48(3):229-38. PubMed ID: 19025795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
    Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
    Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
    Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK
    J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma.
    Rousseau E; Palm T; Scaravilli F; Ruchoux MM; Figarella-Branger D; Salmon I; Ellison D; Lacroix C; Chapon F; Mikol J; Vikkula M; Godfraind C
    Mol Cancer; 2007 Jul; 6():47. PubMed ID: 17626628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.
    Pezzolo A; Capra V; Raso A; Morandi F; Parodi F; Gambini C; Nozza P; Giangaspero F; Cama A; Pistoia V; Garrè ML
    Cancer Lett; 2008 Mar; 261(2):235-43. PubMed ID: 18179864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma.
    Kjellman P; Lagercrantz S; Höög A; Wallin G; Larsson C; Zedenius J
    Genes Chromosomes Cancer; 2001 Sep; 32(1):43-9. PubMed ID: 11477660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.
    Grill J; Avet-Loiseau H; Lellouch-Tubiana A; Sévenet N; Terrier-Lacombe MJ; Vénuat AM; Doz F; Sainte-Rose C; Kalifa C; Vassal G
    Cancer Genet Cytogenet; 2002 Jul; 136(2):121-5. PubMed ID: 12237235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
    Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
    Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.